| Model Number |
72203012 |
| Medical Device Problem Codes |
Suction Problem (2170); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Pulmonary Edema (2020)
|
| Date of Event |
04/05/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Concomitant product: 72205000, control unit(b)(4) hysterolux.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during post operative hysteroscopic myomectomy, no product failure/issues and there were no issues with the hysterolux.Fluid deficit reading increased quickly throughout the procedure.Once deficit limit was reached, an abdominal ultrasound showed free fluid inside patient¿s abdomen.Final fluid deficit was recorded at 2520 cc of ns.Manual count was also performed to confirm correct fluid system reading.Fluid was suctioned off floor in the amount of ~280cc.Patient developed pulmonary edema into post anesthesia care unit.Bilevel positive airway pressure was performed and administration of furosemide.The entire hysteroscopy was approximately 10 minutes.Patient was said to be stable a few hours later.The event lead the patient to stay overnight in the hospital and was discharged the next day.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, post operative hysteroscopic myomectomy, no product failure/issues and there were no issues with the hysterolux during uterine fibroid removal.Pump has been zeroed after priming/during the procedure.The pressure used was 60 mmhg -100 mmhg.Three liters of fluid bag size was used.Normal saline was the distention medium used.Deficit limit was set to 2500cc.Fluid deficit reading increased quickly throughout the procedure.Once deficit limit was reached, an abdominal ultrasound showed free fluid inside patient¿s abdomen.Final fluid deficit was recorded at 2520cc of normal saline.Manual count was also performed to confirm correct fluid system reading and deficit reading.Fluid was suctioned off floor in the amount of ~280cc.The amount suctioned off the floor was subtracted from what the machine was reading.2800cc deficit value was displayed on the pump at the end of the procedure.No fluid has been left in the under-buttocks drapes.Patient developed pulmonary edema into post anesthesia care unit.Bilevel positive airway pressure was performed and administration of furosemide.The entire hysteroscopy was approximately 10 minutes.Patient was said to be stable a few hours later.The event lead the patient to stay overnight in the hospital and was discharged the next day.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|